Rajesh Malik
CIK 1706853 · Chief Medical Officer · last filed 2024-09-18
Rajesh Malik is a Chief Medical Officer who has filed 47 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for GTHX, was dated Sep 18, 2024. Across all open-market trades the lifetime net is −$3.9M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
47
-$3.92M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics, Inc. (GTHX) Delisted | Chief Medical Officer | 177,212 | $7.15 | $1.27M | -$3.94M | 42 | 2024-09-18 |
| POINT Biopharma Global Inc. (PNT) Delisted | Director | 0 | $12.50 | $0 | $24.6K | 5 | 2023-12-27 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-18 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | −159,312 | $0 | EDGAR |
| 2024-07-08 | G1 Therapeutics, Inc. (GTHX) Delisted | Sell (S) | −2,475 | -$6.2K | EDGAR |
| 2024-05-15 | G1 Therapeutics, Inc. (GTHX) Delisted | Sell (S) | −8,151 | -$39.0K | EDGAR |
| 2024-02-13 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | — | -$123.6K | EDGAR |
| 2024-01-08 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | +33,560 | -$11.5K | EDGAR |
| 2023-12-27 | POINT Biopharma Global Inc. (PNT) Delisted | Mixed | −3,700 | $0 | EDGAR |
| 2023-12-13 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | — | -$103.4K | EDGAR |
| 2023-07-07 | G1 Therapeutics, Inc. (GTHX) Delisted | Sell (S) | −1,361 | -$3.3K | EDGAR |
| 2023-06-05 | POINT Biopharma Global Inc. (PNT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-12 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +35,000 | $0 | EDGAR |